Volume 31, Issue 5, Pages (November 2009)

Slides:



Advertisements
Similar presentations
Volume 7, Issue 5, Pages (November 1997)
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 39, Issue 3, Pages (September 2013)
Volume 28, Issue 2, Pages (February 2008)
Volume 43, Issue 4, Pages (October 2015)
Volume 44, Issue 6, Pages (June 2016)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 26, Issue 3, Pages (March 2007)
Wei Hu, Ty Dale Troutman, Ramakrishna Edukulla, Chandrashekhar Pasare 
Volume 45, Issue 5, Pages (November 2016)
Volume 31, Issue 2, Pages (August 2009)
Targeting Toll-like receptors on dendritic cells modifies the TH2 response to peanut allergens in vitro  Pierre Pochard, PhD, Brian Vickery, MD, M. Cecilia.
Volume 18, Issue 4, Pages (April 2003)
Volume 26, Issue 3, Pages e5 (September 2017)
Toll-like Receptor 9: AEP Takes Control
Volume 38, Issue 4, Pages (April 2013)
Volume 18, Issue 5, Pages (May 2003)
Volume 36, Issue 5, Pages (May 2012)
Volume 35, Issue 6, Pages (December 2011)
Volume 47, Issue 5, Pages e6 (November 2017)
Volume 35, Issue 6, Pages (December 2011)
Volume 4, Issue 4, Pages (October 2008)
Volume 27, Issue 2, Pages (August 2007)
IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells
Volume 36, Issue 3, Pages (March 2012)
Volume 43, Issue 6, Pages (December 2015)
Volume 32, Issue 2, Pages (February 2010)
Volume 47, Issue 4, Pages e3 (October 2017)
Volume 22, Issue 4, Pages (April 2005)
Volume 39, Issue 4, Pages (October 2013)
Volume 13, Issue 12, Pages (December 2015)
Volume 24, Issue 2, Pages (February 2006)
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses  Guangxun Meng, Fuping Zhang, Ivan Fuss,
Volume 37, Issue 6, Pages (December 2012)
Volume 25, Issue 5, Pages (November 2006)
Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling
Volume 25, Issue 3, Pages (September 2006)
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Volume 28, Issue 4, Pages (April 2008)
Volume 33, Issue 4, Pages (October 2010)
Volume 22, Issue 2, Pages (February 2005)
Volume 9, Issue 5, Pages (May 2011)
Volume 38, Issue 3, Pages (March 2013)
Volume 32, Issue 4, Pages (April 2010)
Volume 38, Issue 3, Pages (March 2013)
Volume 42, Issue 1, Pages (January 2015)
Volume 24, Issue 3, Pages (March 2006)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 25, Issue 5, Pages (November 2006)
Volume 33, Issue 5, Pages (November 2010)
Volume 43, Issue 4, Pages (October 2015)
Volume 30, Issue 6, Pages (June 2009)
Volume 26, Issue 4, Pages (April 2007)
Volume 40, Issue 4, Pages (April 2014)
Targeted Cleavage of Signaling Proteins by Caspase 3 Inhibits T Cell Receptor Signaling in Anergic T Cells  Irene Puga, Anjana Rao, Fernando Macian  Immunity 
Antigen-Specific Suppression of a Primed Immune Response by Dendritic Cells Mediated by Regulatory T Cells Secreting Interleukin-10  Ela Martin, Brendan.
Volume 38, Issue 2, Pages (February 2013)
Volume 32, Issue 1, Pages (January 2010)
Notch 1 Signaling Regulates Peripheral T Cell Activation
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Volume 38, Issue 1, Pages (January 2013)
Volume 35, Issue 1, Pages (July 2011)
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Volume 156, Issue 4, Pages (February 2014)
Volume 31, Issue 5, Pages (November 2009)
Volume 45, Issue 5, Pages (November 2016)
Engagement of the Type I Interferon Receptor on Dendritic Cells Inhibits T Helper 17 Cell Development: Role of Intracellular Osteopontin  Mari L. Shinohara,
Hepatic Interleukin-7 Expression Regulates T Cell Responses
A Key Role of Leptin in the Control of Regulatory T Cell Proliferation
Volume 25, Issue 3, Pages (September 2006)
Presentation transcript:

Volume 31, Issue 5, Pages 737-748 (November 2009) Critical Role for Asparagine Endopeptidase in Endocytic Toll-like Receptor Signaling in Dendritic Cells  Fernando E. Sepulveda, Sophia Maschalidi, Renaud Colisson, Lea Heslop, Cristina Ghirelli, Emna Sakka, Ana-Maria Lennon-Duménil, Sebastian Amigorena, Lucien Cabanie, Bénédicte Manoury  Immunity  Volume 31, Issue 5, Pages 737-748 (November 2009) DOI: 10.1016/j.immuni.2009.09.013 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Digestion of 35S-Labeled TLR9 with Purified AEP or Disrupted Lysates from WT or AEP-Deficient BMDCs (A) Tlr9 cDNA was transcribed and translated in vitro in the presence of rabbit reticulocyte and 35S-Met. 35S-Met-labeled TLR9 protein was digested or not with 20 μg of WT cell lysate in the absence or presence of the indicated inhibitors for 4 hr. (B) Scheme of murine TLR9 protein (Uniprot accession number Q9EQU3). The 26 LRRs and recognition domain of polyclonal rabbit TLR9 (Santa Cruz) are represented as well as the putative Asn cleavage site, pI, and MW of fragments. (C) Same reaction as (A) via WT (lane 2) or AEP-deficient (KO, lane 3) DC lysate (left). Graphs show mean ± SD (n = 3) via one-way ANOVA test. ∗∗p < 0.01 (right). (D) Same digestion experiments with different doses of rAEP (7.5U, lane 2; 15U, lane 3). The reactions were performed in 50 mM citrate buffer, 0.1% CHAPS (pH 5.5) and separated on a 10% SDS-NuPAGE. ND, nondigested. Representative data from three independent experiments. Immunity 2009 31, 737-748DOI: (10.1016/j.immuni.2009.09.013) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Lack or Severe Delay of TLR9 Processing in Phagosomal Compartments Purified from AEP-Deficient Cells (A) Phagosomes from WT or AEP-deficient (KO) BMDCs were magnetically purified after 20 min or 2 hr. Proteins expressed either in total lysate (50 μg) or in phagosomes (5 μg) were resolved by SDS-PAGE. Early (TfR) and late (LAMP2) markers were visualized by immunoblot. (B and C) Immunodetection of TLR9 proteins in early and late phagosomes from WT or AEP-deficient (KO) BMDCs unstimulated (B) or stimulated (C) with CpG. (D) Same experiments as described in (A) in phagosomes purified from Tlr9−/− DCs. Data are representative of three experiments. Immunity 2009 31, 737-748DOI: (10.1016/j.immuni.2009.09.013) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 CpG Induces TLR9 Processing in an AEP-Dependent Fashion and a Rapid Decrease of Endosomal pH in WT and AEP-Deficient Dendritic Cells (A and B) Lysates from WT (left) or AEP-deficient (KO) BMDCs (right) treated (B) or not (A) with CpG (10 μg/ml) for 30 min, were applied to a size exclusion resin and eluted with 150 mM NaCl, 50 mM Tris (pH 7.4), 5 mM MgCl2. Fractions were collected and were analyzed (5 μg) on a 10% Bis-Tris NuPAGE gel. TLR9, MyD88, and AEP proteins were visualized by immunoblot with TLR9-, MyD88-, and AEP-specific antibodies. (C) Quantification of the fold of increase of the TLR9 processing fragment (C-ter), MyD88, and AEP proteins present in fraction 40 upon CpG stimulation via Image J Software. Graphs show mean ± SD (n = 3). (D) AEP activity in total lysate and purified endosomes from WT BMDCs treated or not with CpG (10 μg/ml) for the indicated time was measured with a specific fluorescent substrate. Graphs show mean ± SD (n = 3) via unpaired t test. ∗p < 0.05. (E) Kinetic of endo-lysosomal pH in WT and AEP-deficient (KO) BMDCs pulsed for 10 min with FITC- and Alexa-647 coupled dextran in the presence or not of 10 μg/ml of CpG and chased for different times. Graphs show mean ± SD (n = 3) via unpaired t test. ∗∗p < 0.01. (F) Effect of endosomal alkalinisation in cytokine secretion upon LPS or CpG stimulation in WT BMDCs. Graphs show mean ± SD (n = 3) via unpaired t test. ∗∗∗p < 0.001. Immunity 2009 31, 737-748DOI: (10.1016/j.immuni.2009.09.013) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 4 AEP Activity Is Required for Full Cytokine Production after TLR9 Stimulation (A and B) BMDCs from WT (black bars) or AEP-deficient (KO) (white bars) mice were stimulated with increasing concentrations of TLR agonist (CpG for TLR9, LPS for TLR4) for 6 hr, and secretion of TNF-α and IL-6 were measured by ELISA. Graphs show mean ± SD (n = 3) via unpaired t test. ∗∗∗p < 0.001. (C–E) Tlr9−/− (C) Myd88−/− (D) AEP-deficient (KO, white bars) and WT (black bars) (E) DCs were transfected with cDNAs encoding GFP, GFP-tagged full-length TLR9, or C-terminal TLR9 fragment and/or AEP (gray bars) at day 8 of culture. After transfection, cells were harvested and stimulated with TLR ligands (CpG, 2 μg/ml; LPS, 10 ng/ml) for 16 hr and secretion of IL-6 (top) and IL-12p40 (bottom) was measured by ELISA. Amount of IL-6 and IL-12p40 produced by unstimulated cells was subtracted from CpG-stimulated cells. (ND, not detected). Graphs show mean ± SD (n = 3). Immunity 2009 31, 737-748DOI: (10.1016/j.immuni.2009.09.013) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 5 Impaired CpG Adjuvancy in AEP Knockout Mice (A and B) IL-6 (A) and IL-12p40 (B) secretion were measured in serum of WT or AEP-deficient (KO) mice after 2 hr of injection i.v. with CpG-B (25 μg) (left), LPS (1 μg) (right), or vehicle alone (PBS). Graphs show mean ± SD (n = 3 via unpaired t test). ∗p < 0.05. (C and D) In vivo proliferation assay of congenic CFSE-labeled OTII T cells (Thy1.1+). Lymphocytes were transferred into Thy1.2+ WT (black bars) or AEP-deficient (KO) mice (white bars) 8 hr before injection of OVA-coated beads i.v. with or without soluble TLR agonist. CFSE dilution and total number of OTII cells in the spleen were measured by flow cytometry. Graphs show mean ± SD (n = 3). Data are representative of three experiments. Immunity 2009 31, 737-748DOI: (10.1016/j.immuni.2009.09.013) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 6 Impaired Cytokine Secretion upon AEP Inhibition in Plasmacytoid Dendritic Cells (A) Spleen-derived plasmacytoid DCs were treated with or without MV026630 (20 μM) and activated with 10 μg/ml of CpG-A. IFN-α secretion was measured by ELISA after overnight culture. Graphs show mean ± SEM (n = 3). (B) Human pDCs isolated from fresh buffy coats were stimulated overnight with CpG-A or CpG-C (5 μg/ml) in the presence or absence of MV026630 (20 μM or at different concentrations) or PI3K (LY, 5 μM). IFN-α secretion was measured by ELISA. Each dot corresponds to pDCs purified from one buffy coat. Immunity 2009 31, 737-748DOI: (10.1016/j.immuni.2009.09.013) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 7 TLR9 Response Is Not Dependent on Cathepsins in AEP-Null Cells whereas Mutating a Putative AEP Cleavage Site in TLR9 Decreases Its Signaling (A) Protein lysates (20 μg) from WT or AEP-deficient (KO) cells were immunoblotted with antibodies for CatB (top left: iCatB, immature CatB; mCatB, mature CatB), CatK (top right: pro-CatK; mCatK, mature CatK), CatL (bottom left: SC, single chain of CatL; HC, heavy chain of CatL), and CatS (bottom right). (B) Cysteine proteases activities from WT or AEP-deficient (KO) BMDCs were monitored with the active site labeling probe DCG-04 that react with their catalytic site. CatB, L, and S were analyzed by immunoprecipitation from DCG-04-labeled BMDC lysates and detection of the biotinylated probe with a streptavidin-linked HRP. (C) Protein lysates (10 μg) of unstimulated (square) or CpG-stimulated (triangles) DCs from WT (black symbols) and AEP-deficient (KO) (white symbols) were assayed for protease activities with specific substrates for CatB, CatB or CatL, and CatS. (D) Immunoblot analysis for CatK expression of protein lysates from CpG-activated WT or AEP-deficient (KO) BMDCs fed or not with pro-CatK. (E) Cells were treated as in (D) and stimulated with different concentrations of CpG for 4 hr, and IL-12p40 secretion was measured by ELISA. Graphs show mean ± SD (n = 3) via unpaired t test. ∗∗∗p < 0.001. (F) Tlr9−/− DCs were transfected with cDNAs encoding GFP-tagged full-length or N466Q TLR9 at day 8 of culture. 24 hr after transfection, cells were harvested and stimulated with TLR ligands (CpG, 2 μg/ml; LPS, 10 ng/ml) for 16 hr, and secretion of IL-6 (left) and IL-12p40 (right) was measured by ELISA. Amount of IL-6 and IL-12p40 produced by unstimulated cells was subtracted from CpG-stimulated cells. ∗p < 0.05. Data are representative of two to three experiments. Immunity 2009 31, 737-748DOI: (10.1016/j.immuni.2009.09.013) Copyright © 2009 Elsevier Inc. Terms and Conditions